Highlights
NASDAQ: HTBX       Heat Biologics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.46   +0.05 (12.20%)  0.406 - 0.507  1,106,200

Overview

 
Avg Volume (4 weeks):433,223
4 Weeks Range:0.37 - 0.649
4 Weeks Price Volatility (%):
32.26%
52 Weeks Range:0.35 - 2.10
52 Weeks Price Volatility (%):
6.29%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Heat Biologics Inc is a US-based immuno-oncology company. It is engaged in developing therapies which activate a patient’s immune system against cancer utilizing an engineered form of gp96. The group’s T cell-stimulating therapeutic vaccine platform technologies, Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT), form the basis of its product candidates. Through ImPACT, it developed product candidates consisting of live, genetically-modified, irradiated human cancer cells which secrete tumor-associated antigens together with an immune response stimulator called gp96. Through ComPACT, the firm engineered product candidates that incorporate ligand fusion proteins targeting co-stimulatory receptors into the gp96-Ig expression vector.

  Be the first to like this.
 


 

4486  3499  717  224 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.702+0.032 
 FCEL 0.81+0.265 
 AMD 37.52+0.81 
 EEM 42.76-0.33 
 ET 11.16-0.50 
 SPY 309.10+0.10 
 GE 11.29-0.13 
 BAC 32.79-0.30 
 DIS 148.72+10.14 
 XLF 29.61-0.19 
Partners & Brokers